Form 4 for ANTX AN2 Therapeutics, Inc.
Accepted 2022-11-09 00:00:00 ET · period of report 2022-11-08 · accession 0000899243-22-035472 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-11-09 | 2022-11-08+ | ANTX | Easom Eric | CEO, Dir | S - Sale | $15.60 | -17.2K | 4,907 | -78% | -$267.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-11-08 | S | D | 1,255 | $16.38 | 15,018 | D | — | — | |
| 2 | Common | Common Stock | 2022-11-08 | S | D | 5,800 | $15.41 | 16,273 | D | — | — | |
| 3 | Common | Common Stock | 2022-11-09 | S | D | 10,111 | $15.61 | 4,907 | D | — | — |